Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Reshma Punjani, Theodore C. Larson, Laurie Wagner, Bryn Davis, D. Kevin Horton & Wendy Kaye. (2023) Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009–2011 and survival through 2018. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 203-211.
Read now
Read now
Orla Hardiman, Mark Heverin, James Rooney, Patricia Lillo, Gladys Godoy, David Sáez, Daniel Valenzuela, Ricardo Hughes, Abayuba Perna, Carlos N. Ketzoian, Cristina Vazquez, Joel Gutierrez Gil, Asdrúbal Arias Morales, Gloria Lara Fernandez, Tatiana Zaldivar, Kevin Horton, Paul Mehta & Giancarlo Logroscino. (2022) The Latin American Epidemiology Network for ALS (Laenals). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 372-377.
Read now
Read now
Paul Mehta, Jaime Raymond, Reshma Punjani, Theodore Larson, Moon Han, Frank Bove & D. Kevin Horton. (2022) Incidence of amyotrophic lateral sclerosis in the United States, 2014–2016. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 378-382.
Read now
Read now
Articles from other publishers (5)
Christina WolfsonDanielle E. GauvinFoluso IsholaMaryam Oskoui. (2023) Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis. Neurology 101:6.
Crossref
Crossref
Benjamin Rix Brooks, James D. Berry, Malgorzata Ciepielewska, Ying Liu, Gustavo Suarez Zambrano, Jeffrey Zhang & Melissa Hagan. (2022) Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis. eClinicalMedicine 52, pages 101590.
Crossref
Crossref
P. S. Goncharova, T. K. Davidova, N. A. Shnayder, M. A. Novitsky & R. F. Nasyrova. (2022) Epidemiology of Amyotrophic Lateral Sclerosis. Personalized Psychiatry and Neurology 2:1, pages 57-66.
Crossref
Crossref
Mai Yamakawa, Sally Dwyer, Xing Song & Jeffrey Statland. (2021)
Demographics, clinical characteristics, and prognostic factors of amyotrophic lateral sclerosis in
M
idwest
. Muscle & Nerve 65:2, pages 217-224.
Crossref
Crossref
Daniel H. Daneshvar, Jesse Mez, Michael L. Alosco, Zachary H. Baucom, Ian Mahar, Christine M. Baugh, Jhaqueline P. Valle, Jennifer Weuve, Sabrina Paganoni, Robert C. Cantu, Ross D. Zafonte, Robert A. Stern, Thor D. Stein, Yorghos Tripodis, Christopher J. Nowinski & Ann C. McKee. (2021) Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes. JAMA Network Open 4:12, pages e2138801.
Crossref
Crossref